Fresenius SE & Co. KGaA Net Assets

Latest as of September 2025: €19.27 Billion EUR ≈ $22.53 Billion USD

Fresenius SE & Co. KGaA net assets. Based on the latest financial reports, Fresenius SE & Co. KGaA (FRE) has net assets worth €19.27 Billion EUR (≈ $22.53 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€42.46 Billion ≈ $49.64 Billion USD) and total liabilities (€23.19 Billion ≈ $27.11 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See debt-free asset ratio of Fresenius SE & Co. KGaA to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets €19.27 Billion
% of Total Assets 45.38%
Annual Growth Rate 8.5%
5-Year Change -22.03%
10-Year Change 7.07%
Growth Volatility 30.53

Net Assets of Fresenius SE & Co. KGaA (2002–2024)

Net assets of Fresenius SE & Co. KGaA from 2002 to 2024. This chart illustrates how Fresenius SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. Also explore FRE shareholders equity momentum to track the company's year-over-year net asset growth rate.

Annual Net Assets for Fresenius SE & Co. KGaA (2002–2024)

The table below shows the annual net assets of Fresenius SE & Co. KGaA from 2002 to 2024. For live market cap and overall valuation, see Fresenius SE & Co. KGaA (FRE) market capitalisation.

Year Net Assets Change
2024-12-31 €20.29 Billion
≈ $23.72 Billion		 +3.25%
2023-12-31 €19.65 Billion
≈ $22.97 Billion		 -39.01%
2022-12-31 €32.22 Billion
≈ $37.67 Billion		 +10.00%
2021-12-31 €29.29 Billion
≈ $34.24 Billion		 +12.55%
2020-12-31 €26.02 Billion
≈ $30.42 Billion		 -2.10%
2019-12-31 €26.58 Billion
≈ $31.07 Billion		 +6.29%
2018-12-31 €25.01 Billion
≈ $29.24 Billion		 +15.14%
2017-12-31 €21.72 Billion
≈ $25.39 Billion		 +0.54%
2016-12-31 €21.60 Billion
≈ $25.26 Billion		 +14.01%
2015-12-31 €18.95 Billion
≈ $22.15 Billion		 +17.24%
2014-12-31 €16.16 Billion
≈ $18.90 Billion		 +17.71%
2013-12-31 €13.73 Billion
≈ $16.05 Billion		 +4.38%
2012-12-31 €13.16 Billion
≈ $15.38 Billion		 +24.38%
2011-12-31 €10.58 Billion
≈ $12.37 Billion		 +19.60%
2010-12-31 €8.84 Billion
≈ $10.34 Billion		 +15.58%
2009-12-31 €7.65 Billion
≈ $8.95 Billion		 +10.21%
2008-12-31 €6.94 Billion
≈ $8.12 Billion		 +108.00%
2007-12-31 €3.34 Billion
≈ $3.90 Billion		 +7.61%
2006-12-31 €3.10 Billion
≈ $3.63 Billion		 +11.74%
2005-12-31 €2.78 Billion
≈ $3.25 Billion		 +73.18%
2004-12-31 €1.60 Billion
≈ $1.87 Billion		 -50.12%
2003-12-31 €3.21 Billion
≈ $3.76 Billion		 -4.60%
2002-12-31 €3.37 Billion
≈ $3.94 Billion		 --

Equity Component Analysis

This analysis shows how different components contribute to Fresenius SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1403800000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Fresenius SE & Co. KGaA Net Assets Breakdown (December 2024)

Fresenius SE & Co. KGaA net assets breakdown by equity component as of December 2024.

Component Amount Percentage
Retained Earnings €14.04 Billion 71.84%
Common Stock €563.00 Million 2.88%
Other Comprehensive Income €626.00 Million 3.20%
Other Components €4.32 Billion 22.08%
Total Equity €19.54 Billion 100.00%

Fresenius SE & Co. KGaA Competitors by Market Cap

The table below lists competitors of Fresenius SE & Co. KGaA ranked by their market capitalization.

Company Market Cap
Givaudan SA
SW:GIVN
 $29.21 Billion
KONE Oyj
HE:KNEBV
 $29.23 Billion
FANUC CORP.UNSP.ADR 1/10
F:FUCA
 $29.28 Billion
King Slide Works Co Ltd
TW:2059
 $29.29 Billion
HOCHTIEF Aktiengesellschaft
F:HOT
 $29.17 Billion
CHINA PAC.IN.GR.GDR/5 YC1
F:75CB
 $29.13 Billion
IMPERIAL BRANDS PLC ADR/1
F:ITBA
 $29.11 Billion
Okta Inc
NASDAQ:OKTA
 $29.11 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Fresenius SE & Co. KGaA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 18,999,000,000 to 19,542,000,000, a change of 543,000,000 (2.9%).
  • Net income of 471,000,000 contributed positively to equity growth.
  • Other comprehensive income increased equity by 608,000,000.
  • Other factors decreased equity by 536,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €471.00 Million +2.41%
Other Comprehensive Income €608.00 Million +3.11%
Other Changes €-536.00 Million -2.74%
Total Change €- 2.86%

Book Value vs Market Value Analysis

This analysis compares Fresenius SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.34x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 €-1.26 €46.46 x
2003-12-31 €-1.15 €46.46 x
2004-12-31 €12.98 €46.46 x
2005-12-31 €21.88 €46.46 x
2006-12-31 €6.68 €46.46 x
2007-12-31 €7.10 €46.46 x
2008-12-31 €8.19 €46.46 x
2009-12-31 €8.78 €46.46 x
2010-12-31 €10.15 €46.46 x
2011-12-31 €12.09 €46.46 x
2012-12-31 €14.55 €46.46 x
2013-12-31 €15.16 €46.46 x
2014-12-31 €17.12 €46.46 x
2015-12-31 €19.91 €46.46 x
2016-12-31 €22.69 €46.46 x
2017-12-31 €24.46 €46.46 x
2018-12-31 €27.60 €46.46 x
2019-12-31 €30.10 €46.46 x
2020-12-31 €30.39 €46.46 x
2021-12-31 €34.04 €46.46 x
2022-12-31 €36.37 €46.46 x
2023-12-31 €33.73 €46.46 x
2024-12-31 €34.70 €46.46 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Fresenius SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 2.41%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.16%
  • • Asset Turnover: 0.50x
  • • Equity Multiplier: 2.23x
  • Recent ROE (2.41%) is below the historical average (10.54%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 0.00% 1.79% 0.84x 0.00x €149.50 Million
2003 0.00% 1.63% 0.85x 0.00x €129.20 Million
2004 10.48% 2.31% 0.89x 5.11x €7.70 Million
2005 8.00% 2.81% 0.68x 4.18x €-55.60 Million
2006 10.64% 3.06% 0.72x 4.84x €19.80 Million
2007 12.28% 3.61% 0.74x 4.59x €76.20 Million
2008 6.91% 2.19% 0.60x 5.25x €-121.00 Million
2009 23.21% 7.00% 0.68x 4.89x €564.00 Million
2010 24.27% 7.54% 0.68x 4.75x €708.50 Million
2011 22.24% 8.04% 0.63x 4.41x €730.90 Million
2012 12.13% 4.80% 0.63x 4.02x €162.70 Million
2013 12.34% 4.97% 0.62x 4.00x €191.50 Million
2014 11.43% 4.59% 0.58x 4.27x €133.50 Million
2015 12.42% 4.92% 0.64x 3.95x €264.50 Million
2016 12.74% 5.48% 0.63x 3.71x €342.70 Million
2017 13.28% 5.35% 0.64x 3.89x €447.90 Million
2018 13.15% 6.05% 0.59x 3.68x €485.90 Million
2019 11.22% 5.32% 0.53x 3.99x €205.20 Million
2020 10.07% 4.71% 0.54x 3.93x €12.10 Million
2021 9.57% 4.85% 0.52x 3.79x €-81.80 Million
2022 6.72% 3.36% 0.53x 3.74x €-669.50 Million
2023 -3.13% -2.66% 0.49x 2.38x €-2.49 Billion
2024 2.41% 2.16% 0.50x 2.23x €-1.48 Billion

Industry Comparison

This section compares Fresenius SE & Co. KGaA's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $4,202,706,718
  • Average return on equity (ROE) among peers: -12.05%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Fresenius SE & Co. KGaA (FRE) €19.27 Billion 0.00% 1.20x $29.19 Billion
China Resources Medical Holdings Company Limited (1PH) $5.60 Billion 7.52% 0.23x $354.05 Million
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) $33.63 Million -111.31% 15.67x $3.30 Million
JINXIN FERT.GRP HD-00001 (3NX) $10.19 Billion 3.38% 0.46x $582.53 Million
REVITALIST L.A.W. LTD (4DO) $-11.05 Million 0.00% 0.00x $744.60K
Wenzhou Kangning Hospital Co. Ltd (4WK) $1.21 Billion 6.69% 0.53x $24.95 Million
HYGEIA HC HLDGS DL-00001 (50I) $4.48 Billion 9.86% 0.49x $11.91K
COMPASS PATHW SP.ADR (5Y6) $181.28 Million -50.48% 0.09x $657.30 Million
Bumrungrad Hospital Public Company Limited (BZ7A) $18.84 Billion 6.39% 0.29x $54.20K
GUANGDONG KANG.CO.LTD YC1 (E9Q) $1.50 Billion 8.08% 0.75x $15.19 Million
Eifelhöhen-Klinik AG (EIF) $17.70 Million -0.65% 2.43x $10.05 Million

About Fresenius SE & Co. KGaA

XETRA:FRE Germany Medical Care Facilities
Market Cap
$30.59 Billion
€26.17 Billion EUR
Market Cap Rank
#902 Global
#198 in Germany
Share Price
€46.46
Change (1 day)
+0.77%
52-Week Range
€35.45 - €52.12
All Time High
€68.67
Categories
Companies in Germany Medical Care Facilities
About

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machin… Read more